Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides

  • Technology appraisal guidance
  • TA805
  • Published: 

History

Documents created during the development process.

Expected publication

Final draft guidance

Draft guidance: 2

Draft guidance

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators